An implant is a medical device that is surgically transplanted in the body to replace or support damaged body organs, enhance their functionalities, or detect flaws in functioning of organs. Medical devices can be placed either permanently or temporarily in the body, and can be removed when they are time-worned. These implantable devices are composed of bones, tissues, skin, ceramics, metals, and other natural materials.

The global implantable medical devices market was valued at $72,265 million in 2015, and is estimated to reach $116,300 million by 2022, registering a CAGR of 7.1% during the forecast period. The market is driven by factors such as rise in prevalence of chronic diseases and rapid increase in geriatric population. Moreover, increased awareness among individuals and rapid technological advancements in the medical implants sector fuel the market growth. However, high cost of implantation and dearth of skilled workforce hamper the market growth. Even then, this market is poised to grow at a CAGR of 10.7% from 2016 to 2022 (in terms of volume).

The global implantable medical devices market is segmented based on product type and geography. Based on product type, the market is categorized into orthopedic implants, dental implants, breast implants, cardiovascular implants, intraocular lenses, and other implants. The orthopedic implants segment contributed the highest revenue to the global market in 2015, owing to the large pool of patients undergoing orthopedic implants due to hyperactive lifestyle, unhealthy food habits, rise in geriatric population, and advancements in medical technologies. The other implants category was the fastest growing segment in 2015, due to increase in prevalence of neurological diseases, craniomaxillofacial deformities, and eye disorders; increase in the rate of cosmetic surgeries; and rise in geriatric population.

The market is segmented on the basis of four regions, namely North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share (nearly half) in the global implantable medical devices market in 2015 due to advancements in implantable medical devices and increase in prevalence of chronic diseases.

The Asia-Pacific region is expected to grow at the highest CAGR of 9.1% during the forecast period. The developing countries in the Asia-Pacific region, such as China and India, provide significant growth opportunities to market players, owing to the large population base and increase in awareness about the benefits of medical implants. Moreover, the report provides comprehensive analyses of the key players operating in the implantable medical devices market.

KEY BENEFITS

The study provides in-depth analyses of the global implantable medical devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis for the period of 2014-2022 to enable stakeholders to capitalize on the prevailing opportunities in the industry.
Extensive analysis of the global market helps in understanding the different types of devices used in the treatment of chronic diseases and other cardiac conditions.
Competitive intelligence of market players highlights the business practices and trends across various regions.

KEY MARKET SEGMENTS

The global implantable medical devices market is segmented based on product type and geography.

By Product

Orthopedic Implants
Spinal Implants
Reconstructive Joint Replacement
Dental Implants
Breast Implants
Cardiovascular Implants
Intraocular Lens
Other Implants

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc.
CONMED Corporation
Globus Medical, Inc.
Integra Lifesciences Holdings Corporation
Johnson & Johnson
LivaNova PLC
Medtronic plc
NuVasive, Inc.
Smith & Nephew plc
St. Jude Medical, Inc.
Institut Straumann AG.
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report, but can be included on request)

Dentsply Sirona Inc.
GC Aesthetics plc
Allergan Inc.
Sientra Inc.
Danaher Corporation
3M Company
Polytech Health & Aesthetics GmbH
B. Braun Melsungen AG
Elixir Medical Corporation
Microport Scientific Corporation
STENTYS S.A.
Terumo Corporation